首页 > 市场调查报告书 > 医疗设备

整形外科

关节内粘稠补充疗法市场规模、份额和成长分析（按产品、应用、原料、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1914053

关节内粘稠补充疗法市场规模、份额和成长分析（按产品、应用、原料、最终用户和地区划分）－2026-2033年产业预测

Viscosupplementation Market Size, Share, and Growth Analysis, By Product (Introduction, Single Injection), By Application (Introduction, Knee Osteoarthritis), By Source, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月02日 | 出版商:

SkyQuest | 英文 183 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球关节内粘稠补充疗法市场规模将达到 53.8 亿美元，到 2025 年将达到 56.8 亿美元，到 2033 年将达到 87.1 亿美元，预测期（2026-2033 年）的复合年增长率为 5.5%。

全球关节内粘稠补充疗法市场正稳定成长，主要驱动力是骨关节炎发病率的上升，尤其是在老年人中。随着对非侵入性治疗方法需求的不断增长，黏液补充疗法已成为理想的治疗方法，有望延缓关节手术。透明质酸产品的进步以及人们对微创手术日益增长的偏好进一步提升了市场的吸引力。关键关节内粘稠补充疗法成长要素包括人们对维持身体机能的日益重视以及运动相关伤害的急剧增加。然而，高昂的治疗费用、保险覆盖范围的限制以及不同患者群体疗效的差异等挑战也阻碍了市场扩张。此外，皮质类固醇注射、物理治疗和口服药物等替代疗法的出现，以及不断变化的法规环境和地区报销政策的差异，都进一步加剧了市场动态的复杂性。

推动全球关节内粘稠补充疗法市场发展的因素

骨关节炎发生率的上升，尤其是在老年人中，是全球关节内粘稠补充疗法市场成长的主要驱动力。随着老龄化，关节劣化的风险增加，从而推动了对非手术镇痛方法（例如透明质酸注射）的需求。这种倾向于微创疗法而非全关节置换术等侵入性手术的趋势，正在已开发市场和新兴市场推动黏性补充疗法的扩张。因此，对有效替代疗法的需求不仅满足了老龄化社会的需求，也刺激了关节内粘稠补充疗法领域的创新和投资。

全球关节内粘稠补充疗法市场面临的限制因素

全球关节内粘稠补充疗法市场面临许多限制因素，其中之一是用于该疗法的先进或品牌透明质酸製剂高成本。此外，不同地区保险覆盖范围的差异或限制也可能阻碍患者选择此疗法。医疗系统面临的经济负担，加上病患的自付费用，严重阻碍了关节内粘稠补充疗法术的普及，尤其是在价格敏感度较高的市场。这可能会抑制该疗法的整体发展和应用，限制有需要的患者获得治疗的机会。

全球关节内粘稠补充疗法市场趋势

全球关节内粘稠补充疗法市场正经历着向单次注射和长效製剂的显着转变，这主要得益于患者和医疗服务提供者对便捷治疗方案日益增长的偏好。单次注射玻尿酸疗法简化了治疗流程，缩短了诊所就诊时间，降低了手术风险，从而提高了患者满意度。同时，长效製剂的推出能够持续润滑关节并缓解疼痛，从而提高患者依从性并改善临床疗效。这一趋势与门诊护理的整体变革相吻合，门诊护理强调以经济有效的方式管理骨关节炎，并致力于创造一个鼓励创新治疗方案的环境。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Sanofi SA（France）
Anika Therapeutics, Inc.（United States）
SEIKAGAKU CORPORATION（Japan）
Zimmer Biomet Holdings, Inc.（United States）
Bioventus Inc.（United States）
Fidia Farmaceutici SpA（Italy）
Ferring Pharmaceuticals（Switzerland）
Johnson & Johnson（United States）
Smith & Nephew plc（United Kingdom）
Avanos Medical, Inc.（United States）
LG Chem, Ltd.（South Korea）
IBSA Institut Biochimique SA（Switzerland）
Hoffmann-La Roche Ltd.（Switzerland）
Teva Pharmaceutical Industries Ltd.（Israel）
Viatris Inc.（United States）
Lifecore Biomedical, LLC（United States）
Aptissen SA（Switzerland）
Chugai Pharmaceutical Co., Ltd.（Japan）
Kolon TissueGene, Inc.（South Korea）
TRB CHEMEDICA SA（Switzerland）

结论与建议

简介目录

Product Code: SQMIG35B2276

Global Viscosupplementation Market size was valued at USD 5.38 Billion in 2024 and is poised to grow from USD 5.68 Billion in 2025 to USD 8.71 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global viscosupplementation market is witnessing consistent growth, primarily driven by the rising incidence of osteoarthritis, especially among the aging population. As demand for non-invasive treatment options escalates, viscosupplementation emerges as a preferred therapy capable of postponing joint surgeries. Advances in hyaluronic acid-based products and a growing preference for minimally invasive procedures further enhance market appeal. Key growth factors include an increased focus on physical mobility and the surging prevalence of sports-related injuries. Nonetheless, market expansion faces challenges such as high treatment costs, reimbursement hurdles, and varying efficacy among patient demographics. Additional alternatives like corticosteroid injections, physical therapy, and oral medications, along with regulatory shifts and regional reimbursement policies, also complicate market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viscosupplementation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viscosupplementation Market Segments Analysis

Global Viscosupplementation Market is segmented by Product, Application, Source, End User and region. Based on Product, the market is segmented into Introduction, Single Injection, Three Injection and Five Injection. Based on Application, the market is segmented into Introduction, Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis and Other Applications. Based on Source, the market is segmented into Introduction, Animal Source and Non-Animal Source. Based on End User, the market is segmented into Introduction, Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCS), Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viscosupplementation Market

The rising incidence of osteoarthritis, particularly among older adults, significantly propels the growth of the global viscosupplementation market. As individuals age, they face heightened risks of joint deterioration, leading to a greater demand for non-surgical pain relief options, such as hyaluronic acid injections. This trend towards minimally invasive therapies, preferred over more invasive procedures like total joint replacements, fosters expansion in both advanced and emerging markets. Consequently, the push for effective alternatives to manage joint pain not only addresses the needs of the aging population but also encourages innovation and investment within the viscosupplementation sector.

Restraints in the Global Viscosupplementation Market

The global viscosupplementation market faces significant restraints due to the high costs associated with advanced or branded hyaluronic acid formulations used in these procedures. Additionally, inconsistent or limited reimbursement policies in various regions can deter patients from pursuing this treatment option. This financial burden on healthcare systems, coupled with out-of-pocket expenses for patients, poses a substantial barrier to broader acceptance of viscosupplementation, particularly in markets where price sensitivity is a critical concern. As a result, the overall growth and adoption of these procedures can be hindered, limiting their availability and accessibility to those in need.

Market Trends of the Global Viscosupplementation Market

The Global Viscosupplementation market is witnessing a significant shift towards single-injection and long-acting formulations, driven by a growing preference for convenient treatment options among patients and healthcare providers. Single-injection hyaluronic acid therapies streamline the treatment process, reducing clinic time and procedural risks, thus enhancing patient satisfaction. Simultaneously, the introduction of long-acting formulations offers extended joint lubrication and sustained pain relief, leading to improved patient compliance and clinical outcomes. This trend aligns with broader changes in outpatient care, highlighting a cost-effective approach to osteoarthritis management while fostering an environment conducive to innovative treatment solutions.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Viscosupplementation Market Size by Product & CAGR (2026-2033)

Market Overview
Introduction
Single Injection
Three Injection
Five Injection

Global Viscosupplementation Market Size by Application & CAGR (2026-2033)

Market Overview
Introduction
Knee Osteoarthritis
Hip Osteoarthritis
Shoulder Osteoarthritis
Other Applications

Global Viscosupplementation Market Size by Source & CAGR (2026-2033)

Market Overview
Introduction
Animal Source
Non-Animal Source

Global Viscosupplementation Market Size by End User & CAGR (2026-2033)

Market Overview
Introduction
Hospitals
Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
Retail Pharmacies
Online Pharmacies

Global Viscosupplementation Market Size & CAGR (2026-2033)

North America (Product, Application, Source, End User)
- US
- Canada
Europe (Product, Application, Source, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, Source, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SEIKAGAKU CORPORATION (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fidia Farmaceutici S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LG Chem, Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBSA Institut Biochimique SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifecore Biomedical, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptissen SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chugai Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kolon TissueGene, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TRB CHEMEDICA SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments